But historically there are groups that are typically neglected due to the current systems in place. Racial disparities are still commonplace in many clinical trials with white-ethnic groups often ...

The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and devices in diverse populations as part of a purge of diversity, equity and ...

Jury testing is a powerful tool in litigation, and attorneys would be well served to think about their cases as studies ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

Leaders of the Common Sense Oncology initiative, launched 1.5 years ago as “a new patient-centered movement in cancer care,” outline principles for trial design, analysis, and reporting.

THEY’RE NOT TRYING TO FILL SLOTS FOR ANY PARTICULAR CLINICAL TRIAL. THE BLUE BRIDGE COMMISSION IS EDUCATION I Blue Bridge, a Roxbury-based group, is leading efforts to increase diversity in ...

In an interview with ACT Associate Editor Don Tracy, Peter Ronco, CEO, Emmes, discusses the "Choosing the Right Allies: ...

Qure is planning soon to start enrolling patients in a second dose group as part of a clinical trial testing AMT-162 for SOD1 ...